- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 354-368 of
1,014 results
2032 Exhibit: Labrie 2004
Document
IPR2017-01910, No. 2032-146 Exhibit - Labrie 2004 (P.T.A.B. Nov. 15, 2017)
|
|
Cite Document
2029 Exhibit: Osborne 2002
Document
IPR2017-01910, No. 2029-143 Exhibit - Osborne 2002 (P.T.A.B. Nov. 15, 2017)
|
|
Cite Document
2052 Exhibit: Sweetana 1996
Document
IPR2017-01910, No. 2052-166 Exhibit - Sweetana 1996 (P.T.A.B. Nov. 15, 2017)
|
|
Cite Document
2068 Exhibit: Baumann 1998
Document
IPR2017-01910, No. 2068-182 Exhibit - Baumann 1998 (P.T.A.B. Nov. 15, 2017)
|
|
Cite Document
1084 Exhibit: Fabian, Clinical Pharmacology of Tamoxifen in Patients with Breast C...
Document
IPR2017-01910, No. 1084-84 Exhibit - Fabian, Clinical Pharmacology of Tamoxifen in Patients with Breast Cancer Correlation with Clinical Data, 48 CANCER 876 82 1981 (P.T.A.B. Aug. 4, 2017)
|
|
Cite Document
1054 Exhibit: Santen, Use of Aromatase Inhibitors in Breast Carcinoma, 6 ENDOCR...
Document
IPR2017-01910, No. 1054-54 Exhibit - Santen, Use of Aromatase Inhibitors in Breast Carcinoma, 6 ENDOCRINE RELATED CANCER 75 92 1999 (P.T.A.B. Aug. 4, 2017)
|
|
Cite Document
1047 Exhibit: US Patent No 5,183,814
Document
IPR2017-01910, No. 1047-47 Exhibit - US Patent No 5,183,814 (P.T.A.B. Aug. 4, 2017)
|
|
Cite Document
1088 Exhibit: Wunsche, Estrogenic Regulation of Clusterin mRNA in Normal and Ma...
Document
IPR2017-01910, No. 1088-88 Exhibit - Wunsche, Estrogenic Regulation of Clusterin mRNA in Normal and Malignant Endometrial Tissue, 76 INT J CANCER 684 88 1998 (P.T.A.B. Aug. 4, 2017)
|
|
Cite Document
1008 Exhibit: McLeskey et al, Tamoxifen resistant fibroblast growth factor transfect...
Document
IPR2017-01910, No. 1008-8 Exhibit - McLeskey et al, Tamoxifen resistant fibroblast growth factor transfected MCF 7 cells are cross resistant in vivo to the antiestrogen ICI 182,780 and two arom...
|
|
Cite Document
1004 Exhibit: Reserved
Document
IPR2017-01910, No. 1004-4 Exhibit - Reserved (P.T.A.B. Aug. 4, 2017)
|
|
Cite Document
1041 Exhibit: Howell, A et al, Clinical Studies With The Specific Pure Antiestrogen IC...
Document
IPR2017-01910, No. 1041-41 Exhibit - Howell, A et al, Clinical Studies With The Specific Pure Antiestrogen ICI 182780, THE BREAST, Vol 5192 195 1996 (P.T.A.B. Aug. 4, 2017)
|
|
Cite Document
1052 Exhibit: Howell, The Definition of the No Change Category in Patients Treated...
Document
IPR2017-01910, No. 1052-52 Exhibit - Howell, The Definition of the No Change Category in Patients Treated with Endocrine Therapy and Chemotherapy for Advanced Carcinoma of the Breast, 2...
|
|
Cite Document
1021 Exhibit: Faslodex Label
Document
IPR2017-01910, No. 1021-21 Exhibit - Faslodex Label (P.T.A.B. Aug. 4, 2017)
|
|
Cite Document
1014 Exhibit: Declaration of Dorraya El Ashry, PhD and Accompanying Exhibits
Document
IPR2017-01910, No. 1014-14 Exhibit - Declaration of Dorraya El Ashry, PhD and Accompanying Exhibits (P.T.A.B. Aug. 4, 2017)
|
|
Cite Document
1113 Exhibit: USP 23 NF 18, The United States Pharmacopeia The National Formul...
Document
IPR2017-01910, No. 1113-113 Exhibit - USP 23 NF 18, The United States Pharmacopeia The National Formulary 13 14 1995 (P.T.A.B. Aug. 4, 2017)
|
|
Cite Document
